Current State and Future Challenges of Mass Spectrometry Imaging for Clinical Research.

The ability of mass spectrometry imaging (MSI) to localize panels of biomolecules in tissues, without prior knowledge of their presence and in a label-free manner, has led to a rapid and substantial impact in clinical and pharmacological research, uncovering biomolecular changes associated with disease and providing low cost imaging of pharmaceuticals. This Feature article will give an introduction to the capabilities and role of MSI in the clinical analysis of patient tissues and discusses those improvements that are necessary for the progression of MSI toward routine clinical application.

[1]  Marie-France Robbe,et al.  imzML--a common data format for the flexible exchange and processing of mass spectrometry imaging data. , 2012, Journal of proteomics.

[2]  Michelle L. Reyzer,et al.  Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. , 2010, Journal of proteome research.

[3]  Brendan Prideaux,et al.  Mass spectrometry imaging for drug distribution studies. , 2012, Journal of proteomics.

[4]  K. Polyak,et al.  Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.

[5]  R. Caprioli,et al.  Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.

[6]  I. Fournier,et al.  Development of liquid microjunction extraction strategy for improving protein identification from tissue sections. , 2013, Journal of proteomics.

[7]  R. Cooks,et al.  Mass Spectrometry Sampling Under Ambient Conditions with Desorption Electrospray Ionization , 2004, Science.

[8]  Mathew Thomas,et al.  High-speed tandem mass spectrometric in situ imaging by nanospray desorption electrospray ionization mass spectrometry. , 2013, Analytical chemistry.

[9]  H. Liebl.  Ion Microprobe Mass Analyzer , 1967 .

[10]  Sage J. B. Dunham,et al.  Biomolecular Imaging with a C60-SIMS/MALDI Dual Ion Source Hybrid Mass Spectrometer: Instrumentation, Matrix Enhancement, and Single Cell Analysis , 2014, Journal of The American Society for Mass Spectrometry.

[11]  Erwan Bezard,et al.  Direct Targeted Quantitative Molecular Imaging of Neurotransmitters in Brain Tissue Sections , 2014, Neuron.

[12]  Alexandra J. Golby,et al.  Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors , 2013, Proceedings of the National Academy of Sciences.

[13]  K. Ligon,et al.  Classifying human brain tumors by lipid imaging with mass spectrometry. , 2012, Cancer research.

[14]  M. Stoeckli,et al.  Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry. , 1999, Analytical chemistry.

[15]  Richard M Caprioli,et al.  Imaging Mass Spectrometry—A New and Promising Method to Differentiate Spitz Nevi From Spitzoid Malignant Melanomas , 2012, The American Journal of dermatopathology.

[16]  Pierre P Massion,et al.  High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometry , 2008, Proteomics.

[17]  A. Feuchtinger,et al.  Novel approach of MALDI drug imaging, immunohistochemistry, and digital image analysis for drug distribution studies in tissues. , 2014, Analytical chemistry.

[18]  L. McDonnell,et al.  30μm spatial resolution protein MALDI MSI: In-depth comparison of five sample preparation protocols applied to human healthy and atherosclerotic arteries. , 2014, Journal of proteomics.

[19]  André M Deelder,et al.  De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry , 2015, The Journal of pathology.

[20]  H. Olsson,et al.  A new look at drugs targeting malignant melanoma—An application for mass spectrometry imaging , 2014, Proteomics.

[21]  Michelle L. Reyzer,et al.  MALDI imaging mass spectrometry: molecular snapshots of biochemical systems , 2007, Nature Methods.

[22]  Jouke Dijkstra,et al.  Automatic registration of mass spectrometry imaging data sets to the Allen brain atlas. , 2014, Analytical chemistry.

[23]  Sören-Oliver Deininger,et al.  MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. , 2008, Journal of proteome research.

[24]  Juan Antonio Vizcaíno,et al.  A public repository for mass spectrometry imaging data , 2014, Analytical and Bioanalytical Chemistry.

[25]  A. Darzi,et al.  Intraoperative Tissue Identification Using Rapid Evaporative Ionization Mass Spectrometry , 2013, Science Translational Medicine.

[26]  Manfred Schmitt,et al.  Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma. , 2014, Journal of proteome research.

[27]  Marius Ueffing,et al.  MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma. , 2012, Journal of proteomics.

[28]  K. Veselkov,et al.  XMS: Cross-Platform Normalization Method for Multimodal Mass Spectrometric Tissue Profiling , 2014, Journal of The American Society for Mass Spectrometry.

[29]  Markus Stoeckli,et al.  iMatrixSpray: a free and open source sample preparation device for mass spectrometric imaging. , 2014, Chimia.

[30]  G. V. Van Berkel,et al.  Thin-layer chromatography and electrospray mass spectrometry coupled using a surface sampling probe. , 2002, Analytical chemistry.

[31]  Richard M Caprioli,et al.  Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics , 2004, Cancer Research.

[32]  A. Walch,et al.  Discussion point: reporting guidelines for mass spectrometry imaging , 2015, Analytical and Bioanalytical Chemistry.

[33]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[34]  Livia S. Eberlin,et al.  Mass spectrometry imaging under ambient conditions. , 2013, Mass spectrometry reviews.

[35]  J. Buhmann,et al.  Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry , 2014, Nature Methods.

[36]  N. Lockyer.  Secondary ion mass spectrometry imaging of biological cells and tissues. , 2014, Methods in molecular biology.

[37]  Robin Patel,et al.  Importance of Using Bruker's Security-Relevant Library for Biotyper Identification of Burkholderia pseudomallei, Brucella Species, and Francisella tularensis , 2013, Journal of Clinical Microbiology.

[38]  V. Moreno,et al.  Cytoxicity and Apoptotic Mechanism of Ruthenium(II) Amino Acid Complexes in Sarcoma-180 Tumor Cells , 2014, PloS one.

[39]  Stefan K. Maier,et al.  Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria , 2013, The Journal of pathology.

[40]  Richard M Caprioli,et al.  Protein signatures for survival and recurrence in metastatic melanoma. , 2011, Journal of proteomics.